These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34330848)
1. Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately. Khan NA; Torralba KD; Aslam F RMD Open; 2021 Jul; 7(2):. PubMed ID: 34330848 [TBL] [Abstract][Full Text] [Related]
2. A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes. Ibrahim F; Tom BD; Scott DL; Prevost AT Trials; 2016 Jun; 17(1):272. PubMed ID: 27255212 [TBL] [Abstract][Full Text] [Related]
3. Handling missing data in RCTs; a review of the top medical journals. Bell ML; Fiero M; Horton NJ; Hsu CH BMC Med Res Methodol; 2014 Nov; 14():118. PubMed ID: 25407057 [TBL] [Abstract][Full Text] [Related]
4. The use of the intention-to-treat principle in nursing clinical trials. Polit DF; Gillespie BM Nurs Res; 2009; 58(6):391-9. PubMed ID: 19918150 [TBL] [Abstract][Full Text] [Related]
5. Intention-to-treat analyses and missing data approaches in pharmacotherapy trials for alcohol use disorders. Del Re AC; Maisel NC; Blodgett JC; Finney JW BMJ Open; 2013 Nov; 3(11):e003464. PubMed ID: 24227870 [TBL] [Abstract][Full Text] [Related]
6. A review of the use of controlled multiple imputation in randomised controlled trials with missing outcome data. Tan PT; Cro S; Van Vogt E; Szigeti M; Cornelius VR BMC Med Res Methodol; 2021 Apr; 21(1):72. PubMed ID: 33858355 [TBL] [Abstract][Full Text] [Related]
7. A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data. Joseph R; Sim J; Ogollah R; Lewis M J Clin Epidemiol; 2015 Jan; 68(1):15-24. PubMed ID: 25304501 [TBL] [Abstract][Full Text] [Related]
8. Current practice in analysing and reporting binary outcome data-a review of randomised controlled trial reports. Rombach I; Knight R; Peckham N; Stokes JR; Cook JA BMC Med; 2020 Jun; 18(1):147. PubMed ID: 32507111 [TBL] [Abstract][Full Text] [Related]
9. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives. Beckett RD; Loeser KC; Bowman KR; Towne TG BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676 [TBL] [Abstract][Full Text] [Related]
10. Intention-to-treat analysis: Are we managing dropouts and missing data properly in research on orthodontic treatment? A systematic review. Barretto Dos Santos Lopes Batista K; Thiruvenkatachari B; O'Brien K Am J Orthod Dentofacial Orthop; 2019 Jan; 155(1):19-27.e3. PubMed ID: 30591159 [TBL] [Abstract][Full Text] [Related]
11. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say? Gravel J; Opatrny L; Shapiro S Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496 [TBL] [Abstract][Full Text] [Related]
12. Missing radiographic data handling in randomized clinical trials in rheumatoid arthritis. Huang X; Jiao L; Wei L; Quan H; Teoh L; Koch GG J Biopharm Stat; 2013; 23(6):1435-52. PubMed ID: 24138441 [TBL] [Abstract][Full Text] [Related]
13. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Brown S; Everett CC; Naraghi K; Davies C; Dawkins B; Hulme C; McCabe C; Pavitt S; Emery P; Sharples L; Buch MH Health Technol Assess; 2018 Jun; 22(34):1-280. PubMed ID: 29900829 [TBL] [Abstract][Full Text] [Related]
14. Missing data were poorly reported and handled in randomized controlled trials with repeatedly measured continuous outcomes: a cross-sectional survey. Ren Y; Jia Y; Huang Y; Zhang Y; Li Q; Yao M; Li L; Li G; Yang M; Yan P; Wang Y; Zou K; Sun X J Clin Epidemiol; 2022 Aug; 148():27-38. PubMed ID: 35436523 [TBL] [Abstract][Full Text] [Related]
15. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis. Khan NA; Lombeida JI; Singh M; Spencer HJ; Torralba KD Arthritis Rheum; 2012 Jul; 64(7):2059-67. PubMed ID: 22275179 [TBL] [Abstract][Full Text] [Related]
16. The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literature. Rombach I; Rivero-Arias O; Gray AM; Jenkinson C; Burke Ó Qual Life Res; 2016 Jul; 25(7):1613-23. PubMed ID: 26821918 [TBL] [Abstract][Full Text] [Related]
17. Loss to analysis in randomized controlled trials in CKD. Deo A; Schmid CH; Earley A; Lau J; Uhlig K Am J Kidney Dis; 2011 Sep; 58(3):349-55. PubMed ID: 21778004 [TBL] [Abstract][Full Text] [Related]
18. Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseases. Baron G; Boutron I; Giraudeau B; Ravaud P Arthritis Rheum; 2005 Jun; 52(6):1858-65. PubMed ID: 15934058 [TBL] [Abstract][Full Text] [Related]
19. A comparison of rheumatoid arthritis and systemic lupus erythematosus trial design: a commentary on ways to improve the number of positive trials in SLE. Miles A; Pope JE Clin Exp Rheumatol; 2015; 33(5):671-80. PubMed ID: 26315693 [TBL] [Abstract][Full Text] [Related]
20. Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic review. Komorowski AS; Bai AD; Cvetkovic A; Mourad O; Lo CKL; Li XX; Mokashi V; Findlater A; Duncan DB; Fuller C; Yamamura D; Mertz D; Clin Microbiol Infect; 2022 May; 28(5):640-648. PubMed ID: 34763055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]